Health Policy

Raw citation data, Impact Factor, Immediacy Index, Published documents, Citations received, , Most cited papers , Recent citations and documents published in this series in EconPapers.

Create citation feed for this series

Raw data:
IF AIF DOC CIT D2Y C2Y SC(%) CiY II AII 1996 0.02 0.18 75 41 171 3 0 0.09 1997 0.02 0.21 92 36 163 4 0 0.08 1998 0.01 0.25 55 38 167 1 0 0.1 1999 0.05 0.32 60 49 147 7 0 0.15 2000 0.05 0.43 60 41 115 6 0 0.19 2001 0.06 0.41 64 34 120 7 0 0.17 2002 0.04 0.44 75 30 124 5 0 0.2 2003 0.04 0.47 104 55 139 5 0 1 0.01 0.22 2004 0.03 0.52 125 53 179 6 0 2 0.02 0.23 2005 0.06 0.56 136 32 229 13 0 5 0.04 0.25 2006 0.04 0.57 148 23 261 11 0 1 0.01 0.24 2007 0.05 0.48 164 13 284 15 0 3 0.02 0.22
IF: Impact Factor: C2Y / D2Y AIF: Average Impact Factor for series in RePEc in year y DOC: Number of documents published in year y CIT: Number of citations to the series in year y D2Y: Number of articles published in y-1 plus y-2 C2Y: Cites in y to articles published in y-1 plus y-2 SC(%): Percentage of selft citations in y to articles published in y-1 plus y-2 CiY: Cites in year y to documents published in year y IdI: Immediacy Index: CiY / Documents.   AII: Average Immediacy Index for series in RePEc in year y
Impact Factor:	Immediacy Index:
Documents published:	Citations received:

Most cited documents in this series:

(1) RePEc:eee:hepoli:v:47:y:1999:i:2:p:97-123 The contingent valuation method in health care (1999).
Cited: 27 times.

(2) RePEc:eee:hepoli:v:54:y:2000:i:2:p:87-123 Review of the literature on reference pricing (2000).
Cited: 11 times.

(3) RePEc:eee:hepoli:v:63:y:2003:i:1:p:17-36 The economic impact of malaria in Africa: a critical review of the evidence (2003).
Cited: 11 times.

(4) RePEc:eee:hepoli:v:24:y:1993:i:3:p:227-238 The trade-off between severity of illness and treatment effect in cost-value analysis of health care (1993).
Cited: 10 times.

(5) RePEc:eee:hepoli:v:37:y:1996:i:1:p:53-72 EuroQol: the current state of play (1996).
Cited: 10 times.

(6) RePEc:eee:hepoli:v:67:y:2004:i:2:p:149-165 Incentives and pharmaceutical reimbursement reforms in Spain (2004).
Cited: 8 times.

(7) RePEc:eee:hepoli:v:52:y:2000:i:1:p:53-70 On hypothetical bias and calibration in cost-benefit studies (2000).
Cited: 7 times.

(8) RePEc:eee:hepoli:v:40:y:1997:i:3:p:237-255 Household income and health care expenditures in Mexico (1997).
Cited: 7 times.

(9) RePEc:eee:hepoli:v:49:y:1999:i:1-2:p:63-74 Public views on health care rationing: a group discussion study (1999).
Cited: 6 times.

(10) RePEc:eee:hepoli:v:57:y:2001:i:2:p:141-153 Scope and scale insensitivities in a contingent valuation study of risk reductions (2001).
Cited: 6 times.

(11) RePEc:eee:hepoli:v:17:y:1991:i:1:p:1-23 Economic evaluation in health care: Is there a role for cost-benefit analysis? (1991).
Cited: 6 times.

(12) RePEc:eee:hepoli:v:65:y:2003:i:1:p:21-35 Needs for further improvement: risk adjustment in the German health insurance system (2003).
Cited: 6 times.

(13) RePEc:eee:hepoli:v:51:y:2000:i:2:p:109-131 An update on Spains health care system: is it time for managed competition? (2000).
Cited: 5 times.

(14) RePEc:eee:hepoli:v:60:y:2002:i:3:p:201-218 Policy relevant determinants of health: an international perspective (2002).
Cited: 5 times.

(15) RePEc:eee:hepoli:v:65:y:2003:i:1:p:5-19 Belgium: risk adjustment and financial responsibility in a centralised system (2003).
Cited: 5 times.

(16) RePEc:eee:hepoli:v:68:y:2004:i:2:p:197-209 The impact of urban health insurance reform on hospital charges: a case study from two cities in China (2004).
Cited: 5 times.

(17) RePEc:eee:hepoli:v:44:y:1998:i:3:p:233-252 Primary health care meets the market in China and Vietnam (1998).
Cited: 5 times.

(18) RePEc:eee:hepoli:v:57:y:2001:i:1:p:1-13 Health economics in low income countries: adapting to the reality of the unofficial economy (2001).
Cited: 5 times.

(19) RePEc:eee:hepoli:v:34:y:1995:i:2:p:135-143 Value for money? A contingent valuation study of the optimal size of the Swedish health care budget (1995).
Cited: 5 times.

(20) RePEc:eee:hepoli:v:60:y:2002:i:3:p:235-254 Free choice of sickness funds in regulated competition: evidence from Germany and The Netherlands (2002).
Cited: 5 times.

(21) RePEc:eee:hepoli:v:51:y:2000:i:1:p:19-30 A qualitative study of the extent to which health gain matters when choosing between groups of patients (2000).
Cited: 5 times.

(22) RePEc:eee:hepoli:v:60:y:2002:i:2:p:133-150 Reforming Chinas urban health insurance system (2002).
Cited: 5 times.

(23) RePEc:eee:hepoli:v:72:y:2005:i:2:p:201-215 Tackling excessive waiting times for elective surgery: a comparative analysis of policies in 12 OECD countries (2005).
Cited: 5 times.

(24) RePEc:eee:hepoli:v:46:y:1998:i:1:p:21-41 The new pharmaceutical policy in Italy (1998).
Cited: 4 times.

(25) RePEc:eee:hepoli:v:65:y:2003:i:1:p:75-98 Risk adjustment and risk selection on the sickness fund insurance market in five European countries (2003).
Cited: 4 times.

(26) RePEc:eee:hepoli:v:31:y:1995:i:2:p:103-110 The use of economic evaluation in health care: Australian decision makers perceptions (1995).
Cited: 4 times.

(27) RePEc:eee:hepoli:v:55:y:2001:i:1:p:51-69 Health-related quality of life by disease and socio-economic group in the general population in Sweden (2001).
Cited: 4 times.

(28) RePEc:eee:hepoli:v:71:y:2005:i:2:p:213-222 Tobacco consumption patterns and its health implications in India (2005).
Cited: 4 times.

(29) RePEc:eee:hepoli:v:32:y:1995:i:1-3:p:125-139 Abnormal economics in the health sector (1995).
Cited: 4 times.

(30) RePEc:eee:hepoli:v:38:y:1996:i:3:p:189-203 Modelling valuations for health states: the effect of duration (1996).
Cited: 4 times.

(31) RePEc:eee:hepoli:v:41:y:1997:i:1:p:1-36 Structured pluralism: towards an innovative model for health system reform in Latin America (1997).
Cited: 4 times.

(32) RePEc:eee:hepoli:v:68:y:2004:i:1:p:47-54 The effect of generic competition on the price of brand-name drugs (2004).
Cited: 4 times.

(33) RePEc:eee:hepoli:v:31:y:1995:i:3:p:183-195 Evaluating the effects of GP remuneration: problems and prospects (1995).
Cited: 4 times.

(34) RePEc:eee:hepoli:v:38:y:1996:i:2:p:117-128 The costs of nursing turnover: evidence from the British National Health Service (1996).
Cited: 4 times.

(35) RePEc:eee:hepoli:v:44:y:1998:i:2:p:123-134 Effects of user charges on the use of prescription medicines in different socio-economic groups (1998).
Cited: 4 times.

(36) RePEc:eee:hepoli:v:69:y:2004:i:1:p:55-72 Technical efficiency in the use of health care resources: a comparison of OECD countries (2004).
Cited: 4 times.

(37) RePEc:eee:hepoli:v:68:y:2004:i:1:p:113-121 The Pharmacy-based Cost Group model: validating and adjusting the classification of medications for chronic conditions to the Dutch situation (2004).
Cited: 4 times.

(38) RePEc:eee:hepoli:v:77:y:2006:i:3:p:268-278 Comparing hospital cost efficiency between Norway and Finland (2006).
Cited: 4 times.

(39) RePEc:eee:hepoli:v:20:y:1992:i:3:p:309-320 Economic evaluation of lipid lowering -- A feasibility test of the contingent valuation approach (1992).
Cited: 4 times.

(40) RePEc:eee:hepoli:v:65:y:2003:i:1:p:63-74 Risk adjustment in Switzerland (2003).
Cited: 4 times.

(41) RePEc:eee:hepoli:v:35:y:1996:i:2:p:155-177 Public autonomous hospitals in sub-Saharan Africa: trends and issues (1996).
Cited: 4 times.

(42) RePEc:eee:hepoli:v:65:y:2003:i:2:p:167-179 The availability of drugs: what does it mean in Ugandan primary care (2003).
Cited: 4 times.

(43) RePEc:eee:hepoli:v:78:y:2006:i:2-3:p:178-193 Health care utilization among persons who are unemployed or outside the labour force (2006).
Cited: 4 times.

(44) RePEc:eee:hepoli:v:38:y:1996:i:3:p:155-171 Is community financing necessary and feasible for rural China? (1996).
Cited: 4 times.

(45) RePEc:eee:hepoli:v:60:y:2002:i:3:p:255-273 A typology for provider payment systems in health care (2002).
Cited: 4 times.

(46) RePEc:eee:hepoli:v:43:y:1998:i:1:p:33-44 Value measurement in cost-utility analysis: explaining the discrepancy between rating scale and person trade-off elicitations (1998).
Cited: 4 times.

(47) RePEc:eee:hepoli:v:58:y:2001:i:1:p:83-96 Policy implications of the inadequate support systems for orphans in Western Kenya (2001).
Cited: 4 times.

(48) RePEc:eee:hepoli:v:52:y:2000:i:2:p:129-145 The cost of prescription medicines to patients (2000).
Cited: 3 times.

(49) RePEc:eee:hepoli:v:66:y:2003:i:1:p:73-93 Service production and contract choice in primary physician services (2003).
Cited: 3 times.

(50) RePEc:eee:hepoli:v:61:y:2002:i:2:p:189-199 Exploring the role of order effects in person trade-off elicitations (2002).
Cited: 3 times.

Recent citations received in: | 2007 | 2006 | 2005 | 2004

Recent citations received in: 2007

(1) RePEc:her:chewps:2007/12 The provision of informal care in terminal illness: An analysis of carersí needs using a discrete choice experiment (2007). CHERE, University of Technology, Sydney / Working Papers

(2) RePEc:pra:mprapa:3354 The advantages and disadvantages of needs-based resource allocation in integrated health systems and market systems of health care provider reimbursement (2007). University Library of Munich, Germany / MPRA Paper

(3) RePEc:pra:mprapa:6093 Hospital Choice: Survey Evidence From Istanbul (2007). University Library of Munich, Germany / MPRA Paper

Recent citations received in: 2006

(1) RePEc:lug:wpaper:0607 Small area variations and welfare loss in the use of antibiotics in the community (2006). Biblioteca universitaria di Lugano (University Library of Lugano) / Quaderni della facoltà di Scienze economiche dell'Università di Lugano

Recent citations received in: 2005

(1) RePEc:cai:meddbu:med_131_0011 Carences institutionnelles et rationnement de laccès à la santé dans les pays en développement : repères et enjeux (2005). Mondes en développement

(2) RePEc:fda:fdaddt:2005-15 Measuring Changes in Health Capital (2005). FEDEA / Working Papers

(3) RePEc:ind:igiwpp:2005-003 Price elasticity estimates for tobacco and other addictive goods in India (2005). Indira Gandhi Institute of Development Research, Mumbai, India / Indira Gandhi Institute of Development Research, Mumbai Working Papers

(4) RePEc:ssa:lemwps:2005/24 Innovation and Standards in Clinical Practice: The Case of HIV Treatments (2005). Laboratory of Economics and Management (LEM), Sant'Anna School of Advanced Studies, Pisa, Italy / LEM Papers Series

(5) RePEc:wly:hlthec:v:14:y:2005:i:s1:p:s187-s202 The Italian health-care system (2005). Health Economics

Recent citations received in: 2004

(1) RePEc:upf:upfgen:762 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain (2004). Department of Economics and Business, Universitat Pompeu Fabra / Economics Working Papers

(2) RePEc:upf:upfses:762 Regulatory Ambivalence and the Limitations of Pharmaceutical Policy in Spain (2004). Department of Economics and Business, Universitat Pompeu Fabra / Working Papers, Research Center on Health and Economics

Warning!! This is still an experimental service. The results of this service should be interpreted with care, especially in research assessment exercises. The processing of documents is automatic. There still are errors and omissions in the identification of references. We are working to improve the software to increase the accuracy of the results.

Source data used to compute the impact factor of RePEc series.